Digital PCR and Real-Time PCR Market anticipated to grow at a CAGR of 8% by 2025Posted by Faraz on January 10th, 2020 The digital PCR and real-time PCR market have anticipated to grow at a CAGR of 8% during the forecast period attributed to advancements in technology. The Digital Chain Reaction (dPCR) is a method for the quantification of target nucleic acids. The different aspects of PCR assay that includes nanotechnology, microfluidics, and robotics, that enables in the rapid advancement of new procedures. The DNA chips, DNA microarray, and real-time PCR use these new technologies in conjunction with computer programs and computers. The reverse transcription-PCR and PCR assays have accelerated the speed and accuracy of diagnosis in animal and human diseases. The genetic sequences for selection and validation have greatly facilitated through the establishment of machines, computer programs, and new sequencing techniques. Get Sample Copy of Digital PCR and Real-Time PCR Market at: https://www.omrglobal.com/request-sample/digital-pcr-and-real-time-pcr-market The key players of digital PCR and real-time PCR market include Agilent Technologies, Inc., BioMérieux S.A., Fluidigm Corp., Abbott Laboratories, Inc., Merck KGaA, Becton Dickinson and Company, Thermo Fisher Scientific Inc, QIAGEN N.V., Bio-Rad Laboratories, and Siemens AG. There are such libraries named as genetic libraries for the development and validations of molecular-based diagnostics procedures concerning human and veterinary diseases agents include Genbank. There are tools that are being incorporated for hand-held PCR assays due to technological advancement contributing towards the growth of the Digital PCR and real-time PCR market. Recent Activities In September 2018, Thermo Fisher Scientific Inc. has launched VetMax MastiType, it is qPCR-based test kit that utilized for the detection of mastitis pathogens in dairy herds. In January 2019, QIAGEN N.V. has done the acquisition of FORMULATRIX digital PCR. The acquisition has with the company strategy of launching new digital PCR by incorporating advanced dPCR technology. In February 2019, Bio-Rad laboratories, Inc. have received FDA (Food and Drug Administration) approval for QxDx Auto DG dPCR system. In January 2019, Qiagen N.V. has announced the establishment of the next-generation system in the life science industry for dPCR. Current Market Trends Covered in the Report Based on technology, the digital segment is the fastest-growing segment owing to the qualification of target sequences. North America holds the largest growth during the forecast period owing to the development of new PCR products. Asia-Pacific is anticipated to be the fastest-growing segment during the forecast period. Based on products, reagents and consumables have the largest segment owed to the use of PCR kits in the diagnostics test. For More Information get A full report of Digital PCR and Real-Time PCR is available at: https://www.omrglobal.com/industry-reports/digital-pcr-and-real-time-pcr-market Global Digital PCR and Real-time PCR Market Segmentation By Technology
By-Products
By Application
Global Digital PCR and Real-time PCR Market – Segment by Region North America
Europe
Rest of Europe Asia-Pacific
Rest of Asia-Pacific Rest of the World
About Orion Market Research OMR provide global and regional market reports of various domains such as healthcare, energy, IT, chemicals, and automobiles. OMR provide a 360-degree view of the market with parametric analysis, key market insights, key findings, statistical forecasts, competitive landscape, extensive segmentation, key trends, strategic recommendations and detailed company profiles. For More Information, Visit Orion Market Research Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 7803040404 Source: Global Digital PCR and Real-Time PCR Market Like it? Share it! More by this author |